EnteroMedics Inc.
ETRM
ETRM was delisted on the 20th of October, 2017.
26 hedge funds and large institutions have $1.08M invested in EnteroMedics Inc. in 2016 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 12 closing their positions.
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
21% less funds holding
Funds holding: 33 → 26 (-7)
39% less capital invested
Capital invested by funds: $1.75M → $1.08M (-$678K)
58% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 12
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $48K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$236K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$39.8K |
| 3 |
Goldman Sachs
New York
|
+$36.4K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
+$23.1K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$23K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$58.6K |
| 2 |
Morgan Stanley
New York
|
-$27.2K |
| 3 |
California Public Employees Retirement System
Sacramento,
California
|
-$14K |
| 4 |
Bank of New York Mellon
New York
|
-$13K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$9K |
ETRM Hedge Fund Activity: Q1 2016 in Review
26 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in EnteroMedics Inc. (ETRM) for Q1 2016, worth a combined $1.08M — down 39% from $1.75M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of ETRM and 5 opened new positions — a net loss of 7 holders — while 5 trimmed existing stakes and 6 added.
The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $236K. The largest seller was Vanguard Group, cutting an estimated $58.6K.
- 26 institutional investors held EnteroMedics Inc. (ETRM) as of Q1 2016, down from 33 in Q4 2015.
- Funds reported $1.08M of EnteroMedics Inc. stock for Q1 2016, down 39% quarter-over-quarter.
- 5 funds opened new EnteroMedics Inc. positions in Q1 2016 and 12 closed out, a net change of -7 holders.
- The largest EnteroMedics Inc. buyer in Q1 2016 was Hudson Bay Capital Management, an estimated $236K added.
- The largest EnteroMedics Inc. seller in Q1 2016 was Vanguard Group, an estimated $58.6K sold.
Based on aggregated 13F filings for Q1 2016.